The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1481
November 9, 2015
View Complete Issue         Table of Contents 2019 
A Sumatriptan Patch (Zecuity) for Migraine
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
A Sumatriptan Patch (Zecuity) for Migraine
November 9, 2015 (Issue: 1481)
The FDA has approved a sumatriptan iontophoretic transdermal system (Zecuity – Teva) for acute treatment of migraine in adults. Sumatriptan, the first of seven serotonin receptor antagonists (triptans) approved for this indication, is the most...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: A Sumatriptan Patch (Zecuity) for Migraine
Article code: 1481a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.